Handelsbanken Fonder’s OptimizeRx OPRX Stock Holding History

Handelsbanken Fonder’s Portfolio OPRX Stock Details OPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-230,500	Closed	-$3.87M	–	1577
2022 Q4	$3.87M	Sell	230,500 -285,600	-55%	-$4.94M	0.02%	442
2022 Q3	$7.65M	Hold	516,100	–	–	0.05%	328
2022 Q2	$14.1M	Sell	516,100 -28,900	-5%	-$856K	0.09%	222
2022 Q1	$20.6M	Sell	545,000 -15,000	-3%	-$664K	0.11%	189
2021 Q4	$34.8M	Buy	560,000 +49,500	+10%	+$3.75M	0.17%	137
2021 Q3	$43.7M	Sell	510,500 -100,000	-16%	-$6.27M	0.23%	103
2021 Q2	$37.8M	Buy	610,500 +30,000	+5%	+$1.53M	0.2%	111
2021 Q1	$28.3M	Sell	580,500 -29,500	-5%	-$1.42M	0.16%	138
2020 Q4	$19M	Buy	610,000 +220,000	+56%	+$5.39M	0.12%	183
2020 Q3	$8.13M	Buy	+390,000	New	+$6.7M	0.06%	274

Other funds holding OPRX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

GIPM

G2 Investment Partners Management New York $406M AUM 164.47% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Handelsbanken Fonder's OPRX Position: Q1 2023 in Review

Handelsbanken Fonder sold out of OptimizeRx (OPRX) in Q1 2023, closing a stake of 230,500 shares — an estimated $3.87M sold.

Handelsbanken Fonder first reported a position in OPRX in Q3 2020 and held it in 10 quarters. The position peaked at $43.7M in Q3 2021. 110 funds tracked by Wall St. Rank hold OPRX as of Q1 2023.

Handelsbanken Fonder reported no remaining OptimizeRx position as of Q1 2023 after selling out during the quarter.
Handelsbanken Fonder sold 230,500 OptimizeRx shares in Q1 2023, an estimated $3.87M.
Handelsbanken Fonder first reported a position in OptimizeRx in Q3 2020 and held it in 10 quarters.
Handelsbanken Fonder's OptimizeRx position peaked at $43.7M in Q3 2021.
110 funds tracked by Wall St. Rank held OptimizeRx as of Q1 2023.

Based on Handelsbanken Fonder's 13F filing for Q1 2023, filed 28 Apr 2023.